Business Intelligence on Retailing, Franchising, and Consumerism in China

China Jo-Jo Faces Delisting In USA

Chinese pharmaceutical and healthcare products provider China Jo-Jo Drugstores Inc. was notified last week that it may soon be delisted.

Nasdaq notified the company of its failure to maintain a minimum closing bid price of USD1.00 over the then preceding 30 consecutive trading days for its common stock as required by Nasdaq Listing Rule 5550(a)(2). The company has until November 5, 2013, to regain compliance.

The company says it intends to actively monitor the bid price for its common stock between now and November 5, 2013, and will consider available options to resolve the deficiency and regain compliance with the minimum bid price requirement.

As of March 31, 2013, the company says it has 52 retail pharmacies throughout Zhejiang province and Shanghai.

Be the first to comment on "China Jo-Jo Faces Delisting In USA"

Leave a comment

Your email address will not be published.


  Other China News

AutoNavi, Delphi Reach Deal

Hisense's Net Profit Down 47.39% In First Three Quarters Of 2017

Airbnb China Head Resigns

DMG To Buy China Rights Of Forbes Brand


Chinese Electric Bus Manufacturer Lands USA Deal

American Electric Car Manufacturer To Build In China

U.S. Clean Water Company Makes Chinese Inroads

GE Will Promote Wind Power Through New Chinese Education Center

JD To Build Global Logistics Headquarters In Xi'an

Wumart, AGS Sign Agreement For Seafood Direct Procurement

India Gains Second Factory From China's Xiaomi

85% of Indian Staff To Lose Jobs At China's LeEco